Cessation of Bezafibrate in patients with chronic kidney disease improves renal function

Bezafibrate (BzF) is eliminated by renal excretion and dosage must be reduced in patients with chronic kidney disease (CKD). There is a concern that BzF causes a further deterioration in renal function in patients with CKD. This study assessed whether BzF discontinuation or dose reduction in CKD pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingerman, Boris, Ziv, Danny, Feder Krengel, Netta, Korzets, Asher, Matok, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666122/
https://www.ncbi.nlm.nih.gov/pubmed/33188240
http://dx.doi.org/10.1038/s41598-020-76861-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666122/
https://www.ncbi.nlm.nih.gov/pubmed/33188240
http://dx.doi.org/10.1038/s41598-020-76861-1

Ejemplares similares